nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—esophageal cancer	0.544	1	CbGaD
Clodronate—PTGS2—Cisplatin—esophageal cancer	0.0374	1	CbGbCtD
Clodronate—SLC25A6—exocrine gland—esophageal cancer	0.0191	0.126	CbGeAlD
Clodronate—SLC25A5—exocrine gland—esophageal cancer	0.0167	0.11	CbGeAlD
Clodronate—Hepatic cancer metastatic—Capecitabine—esophageal cancer	0.0132	0.138	CcSEcCtD
Clodronate—Metastases to liver—Capecitabine—esophageal cancer	0.0132	0.138	CcSEcCtD
Clodronate—SLC25A6—neck—esophageal cancer	0.0122	0.0807	CbGeAlD
Clodronate—SLC25A5—neck—esophageal cancer	0.0106	0.0702	CbGeAlD
Clodronate—SLC25A6—epithelium—esophageal cancer	0.00833	0.0549	CbGeAlD
Clodronate—SLC25A6—bronchus—esophageal cancer	0.0082	0.0541	CbGeAlD
Clodronate—SLC25A5—epithelium—esophageal cancer	0.00724	0.0478	CbGeAlD
Clodronate—SLC25A5—bronchus—esophageal cancer	0.00713	0.047	CbGeAlD
Clodronate—SLC25A5—smooth muscle tissue—esophageal cancer	0.00698	0.046	CbGeAlD
Clodronate—SLC25A5—trachea—esophageal cancer	0.00641	0.0422	CbGeAlD
Clodronate—SLC25A6—digestive system—esophageal cancer	0.00633	0.0418	CbGeAlD
Clodronate—Extravasation—Carboplatin—esophageal cancer	0.00585	0.0611	CcSEcCtD
Clodronate—SLC25A5—digestive system—esophageal cancer	0.00551	0.0363	CbGeAlD
Clodronate—SLC25A6—lung—esophageal cancer	0.00529	0.0349	CbGeAlD
Clodronate—Acute leukaemia—Cisplatin—esophageal cancer	0.00524	0.0548	CcSEcCtD
Clodronate—SLC25A4—digestive system—esophageal cancer	0.00516	0.0341	CbGeAlD
Clodronate—SLC25A5—lung—esophageal cancer	0.0046	0.0304	CbGeAlD
Clodronate—SLC25A4—lung—esophageal cancer	0.00431	0.0284	CbGeAlD
Clodronate—SLC25A6—lymph node—esophageal cancer	0.00362	0.0239	CbGeAlD
Clodronate—Zoledronate—CA2—esophageal cancer	0.00318	1	CrCbGaD
Clodronate—SLC25A5—lymph node—esophageal cancer	0.00315	0.0208	CbGeAlD
Clodronate—SLC25A4—lymph node—esophageal cancer	0.00295	0.0195	CbGeAlD
Clodronate—Serum creatinine increased—Cisplatin—esophageal cancer	0.00244	0.0254	CcSEcCtD
Clodronate—Infection—Carboplatin—esophageal cancer	0.00181	0.0189	CcSEcCtD
Clodronate—Serum creatinine increased—Capecitabine—esophageal cancer	0.00179	0.0188	CcSEcCtD
Clodronate—Extravasation—Cisplatin—esophageal cancer	0.00172	0.0179	CcSEcCtD
Clodronate—Hypercalcaemia—Capecitabine—esophageal cancer	0.00159	0.0166	CcSEcCtD
Clodronate—Hepatocellular injury—Cisplatin—esophageal cancer	0.0015	0.0156	CcSEcCtD
Clodronate—Wheezing—Cisplatin—esophageal cancer	0.00145	0.0152	CcSEcCtD
Clodronate—PTGS2—epithelium—esophageal cancer	0.00136	0.009	CbGeAlD
Clodronate—PTGS2—bronchus—esophageal cancer	0.00134	0.00886	CbGeAlD
Clodronate—PTGS2—smooth muscle tissue—esophageal cancer	0.00131	0.00867	CbGeAlD
Clodronate—Proteinuria—Capecitabine—esophageal cancer	0.00126	0.0131	CcSEcCtD
Clodronate—Protein urine present—Capecitabine—esophageal cancer	0.00124	0.0129	CcSEcCtD
Clodronate—PTGS2—trachea—esophageal cancer	0.00121	0.00795	CbGeAlD
Clodronate—Hypocalcaemia—Capecitabine—esophageal cancer	0.00121	0.0126	CcSEcCtD
Clodronate—Liver disorder—Methotrexate—esophageal cancer	0.00121	0.0126	CcSEcCtD
Clodronate—Renal failure acute—Cisplatin—esophageal cancer	0.00118	0.0123	CcSEcCtD
Clodronate—PTGS2—digestive system—esophageal cancer	0.00104	0.00684	CbGeAlD
Clodronate—Blood creatinine increased—Cisplatin—esophageal cancer	0.00102	0.0106	CcSEcCtD
Clodronate—Dehydration—Cisplatin—esophageal cancer	0.00101	0.0106	CcSEcCtD
Clodronate—Extravasation—Methotrexate—esophageal cancer	0.000942	0.00984	CcSEcCtD
Clodronate—Proteinuria—Methotrexate—esophageal cancer	0.000935	0.00977	CcSEcCtD
Clodronate—Protein urine present—Methotrexate—esophageal cancer	0.000923	0.00964	CcSEcCtD
Clodronate—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000917	0.00958	CcSEcCtD
Clodronate—Oliguria—Methotrexate—esophageal cancer	0.000892	0.00932	CcSEcCtD
Clodronate—Renal failure acute—Capecitabine—esophageal cancer	0.000868	0.00907	CcSEcCtD
Clodronate—PTGS2—lung—esophageal cancer	0.000867	0.00572	CbGeAlD
Clodronate—Renal impairment—Capecitabine—esophageal cancer	0.000842	0.0088	CcSEcCtD
Clodronate—Renal failure—Cisplatin—esophageal cancer	0.000824	0.0086	CcSEcCtD
Clodronate—Cardiac failure—Capecitabine—esophageal cancer	0.000821	0.00858	CcSEcCtD
Clodronate—Blood creatinine increased—Capecitabine—esophageal cancer	0.000751	0.00784	CcSEcCtD
Clodronate—Dehydration—Capecitabine—esophageal cancer	0.000745	0.00779	CcSEcCtD
Clodronate—Urinary tract disorder—Cisplatin—esophageal cancer	0.000743	0.00776	CcSEcCtD
Clodronate—Connective tissue disorder—Cisplatin—esophageal cancer	0.000739	0.00772	CcSEcCtD
Clodronate—Urethral disorder—Cisplatin—esophageal cancer	0.000737	0.0077	CcSEcCtD
Clodronate—Abdominal pain upper—Capecitabine—esophageal cancer	0.000732	0.00765	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000707	0.00738	CcSEcCtD
Clodronate—Dysphagia—Capecitabine—esophageal cancer	0.000693	0.00724	CcSEcCtD
Clodronate—Bronchospasm—Capecitabine—esophageal cancer	0.000681	0.00712	CcSEcCtD
Clodronate—Mediastinal disorder—Cisplatin—esophageal cancer	0.000678	0.00708	CcSEcCtD
Clodronate—Renal failure acute—Methotrexate—esophageal cancer	0.000646	0.00675	CcSEcCtD
Clodronate—Pneumonia—Capecitabine—esophageal cancer	0.000621	0.00649	CcSEcCtD
Clodronate—Renal failure—Capecitabine—esophageal cancer	0.000607	0.00634	CcSEcCtD
Clodronate—Anaemia—Cisplatin—esophageal cancer	0.000605	0.00632	CcSEcCtD
Clodronate—PTGS2—lymph node—esophageal cancer	0.000593	0.00391	CbGeAlD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000554	0.00578	CcSEcCtD
Clodronate—Pharyngitis—Capecitabine—esophageal cancer	0.00055	0.00575	CcSEcCtD
Clodronate—Urinary tract disorder—Capecitabine—esophageal cancer	0.000548	0.00572	CcSEcCtD
Clodronate—Connective tissue disorder—Capecitabine—esophageal cancer	0.000545	0.00569	CcSEcCtD
Clodronate—Urethral disorder—Capecitabine—esophageal cancer	0.000544	0.00568	CcSEcCtD
Clodronate—Infection—Cisplatin—esophageal cancer	0.000531	0.00555	CcSEcCtD
Clodronate—Skin disorder—Cisplatin—esophageal cancer	0.000519	0.00542	CcSEcCtD
Clodronate—Anorexia—Cisplatin—esophageal cancer	0.000509	0.00532	CcSEcCtD
Clodronate—Mediastinal disorder—Capecitabine—esophageal cancer	0.0005	0.00522	CcSEcCtD
Clodronate—Dyspnoea—Cisplatin—esophageal cancer	0.000476	0.00498	CcSEcCtD
Clodronate—Decreased appetite—Cisplatin—esophageal cancer	0.000465	0.00485	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—esophageal cancer	0.000462	0.00483	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000461	0.00482	CcSEcCtD
Clodronate—Renal failure—Methotrexate—esophageal cancer	0.000452	0.00472	CcSEcCtD
Clodronate—Anaemia—Capecitabine—esophageal cancer	0.000446	0.00466	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—esophageal cancer	0.00041	0.00428	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000408	0.00426	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—esophageal cancer	0.000408	0.00426	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—esophageal cancer	0.000405	0.00423	CcSEcCtD
Clodronate—Infection—Capecitabine—esophageal cancer	0.000391	0.00409	CcSEcCtD
Clodronate—Skin disorder—Capecitabine—esophageal cancer	0.000383	0.004	CcSEcCtD
Clodronate—Anorexia—Capecitabine—esophageal cancer	0.000375	0.00392	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—esophageal cancer	0.000372	0.00389	CcSEcCtD
Clodronate—Diarrhoea—Cisplatin—esophageal cancer	0.000366	0.00382	CcSEcCtD
Clodronate—Dyspnoea—Capecitabine—esophageal cancer	0.000351	0.00367	CcSEcCtD
Clodronate—Dyspepsia—Capecitabine—esophageal cancer	0.000347	0.00362	CcSEcCtD
Clodronate—Decreased appetite—Capecitabine—esophageal cancer	0.000342	0.00358	CcSEcCtD
Clodronate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00034	0.00355	CcSEcCtD
Clodronate—Vomiting—Cisplatin—esophageal cancer	0.00034	0.00355	CcSEcCtD
Clodronate—Rash—Cisplatin—esophageal cancer	0.000337	0.00352	CcSEcCtD
Clodronate—Dermatitis—Cisplatin—esophageal cancer	0.000337	0.00352	CcSEcCtD
Clodronate—Anaemia—Methotrexate—esophageal cancer	0.000332	0.00347	CcSEcCtD
Clodronate—Nausea—Cisplatin—esophageal cancer	0.000317	0.00332	CcSEcCtD
Clodronate—Urticaria—Capecitabine—esophageal cancer	0.000313	0.00327	CcSEcCtD
Clodronate—Abdominal pain—Capecitabine—esophageal cancer	0.000311	0.00325	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000304	0.00317	CcSEcCtD
Clodronate—SLC25A5—Disease—ENO1—esophageal cancer	0.000304	0.0018	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ADH7—esophageal cancer	0.000302	0.00179	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PLCE1—esophageal cancer	0.000302	0.00179	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—GHRL—esophageal cancer	0.0003	0.00178	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PSME1—esophageal cancer	0.000299	0.00178	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PSME2—esophageal cancer	0.000299	0.00178	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—FBXW7—esophageal cancer	0.000295	0.00175	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTO1—esophageal cancer	0.000293	0.00174	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—TPI1—esophageal cancer	0.000293	0.00174	CbGpPWpGaD
Clodronate—Infection—Methotrexate—esophageal cancer	0.000291	0.00304	CcSEcCtD
Clodronate—SLC25A5—Disease—CALR—esophageal cancer	0.000287	0.0017	CbGpPWpGaD
Clodronate—SLC25A6—Disease—XIAP—esophageal cancer	0.000285	0.0017	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALDH2—esophageal cancer	0.000285	0.00169	CbGpPWpGaD
Clodronate—Skin disorder—Methotrexate—esophageal cancer	0.000285	0.00298	CcSEcCtD
Clodronate—SLC25A6—Metabolism—ALDOB—esophageal cancer	0.000281	0.00167	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ELMO1—esophageal cancer	0.00028	0.00166	CbGpPWpGaD
Clodronate—Anorexia—Methotrexate—esophageal cancer	0.00028	0.00292	CcSEcCtD
Clodronate—Pruritus—Capecitabine—esophageal cancer	0.000279	0.00291	CcSEcCtD
Clodronate—SLC25A5—Disease—FBXW7—esophageal cancer	0.000278	0.00165	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL2—esophageal cancer	0.000274	0.00163	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TPI1—esophageal cancer	0.000273	0.00162	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GSTO1—esophageal cancer	0.000273	0.00162	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTT1—esophageal cancer	0.000271	0.00161	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GAPDH—esophageal cancer	0.000271	0.00161	CbGpPWpGaD
Clodronate—Diarrhoea—Capecitabine—esophageal cancer	0.00027	0.00282	CcSEcCtD
Clodronate—SLC25A6—Metabolism—CRABP1—esophageal cancer	0.000268	0.00159	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP2A6—esophageal cancer	0.000268	0.00159	CbGpPWpGaD
Clodronate—SLC25A6—Disease—B2M—esophageal cancer	0.000265	0.00158	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ADH1B—esophageal cancer	0.000265	0.00157	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ALDOB—esophageal cancer	0.000262	0.00156	CbGpPWpGaD
Clodronate—Dyspnoea—Methotrexate—esophageal cancer	0.000261	0.00273	CcSEcCtD
Clodronate—Dyspepsia—Methotrexate—esophageal cancer	0.000258	0.0027	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000258	0.00153	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000255	0.00151	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GNG7—esophageal cancer	0.000255	0.00151	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—ANXA1—esophageal cancer	0.000255	0.00151	CbGpPWpGaD
Clodronate—Decreased appetite—Methotrexate—esophageal cancer	0.000255	0.00266	CcSEcCtD
Clodronate—SLC25A6—Disease—ENO1—esophageal cancer	0.000254	0.00151	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS1—esophageal cancer	0.000254	0.00151	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ENO1—esophageal cancer	0.000254	0.00151	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000253	0.00264	CcSEcCtD
Clodronate—SLC25A4—Metabolism—TYMP—esophageal cancer	0.000253	0.0015	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HIST1H2BM—esophageal cancer	0.000252	0.0015	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GAPDH—esophageal cancer	0.000252	0.0015	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PSME1—esophageal cancer	0.000251	0.00149	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PSME2—esophageal cancer	0.000251	0.00149	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PSME1—esophageal cancer	0.000251	0.00149	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PSME2—esophageal cancer	0.000251	0.00149	CbGpPWpGaD
Clodronate—Vomiting—Capecitabine—esophageal cancer	0.00025	0.00262	CcSEcCtD
Clodronate—Rash—Capecitabine—esophageal cancer	0.000248	0.00259	CcSEcCtD
Clodronate—Dermatitis—Capecitabine—esophageal cancer	0.000248	0.00259	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CYP26A1—esophageal cancer	0.000246	0.00146	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CALR—esophageal cancer	0.000241	0.00143	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALOX15—esophageal cancer	0.00024	0.00142	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALDH2—esophageal cancer	0.000239	0.00142	CbGpPWpGaD
Clodronate—Nausea—Capecitabine—esophageal cancer	0.000234	0.00244	CcSEcCtD
Clodronate—Urticaria—Methotrexate—esophageal cancer	0.000233	0.00243	CcSEcCtD
Clodronate—SLC25A6—Disease—FBXW7—esophageal cancer	0.000233	0.00138	CbGpPWpGaD
Clodronate—Abdominal pain—Methotrexate—esophageal cancer	0.000232	0.00242	CcSEcCtD
Clodronate—SLC25A4—Metabolism—TPI1—esophageal cancer	0.000229	0.00136	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTO1—esophageal cancer	0.000229	0.00136	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTT1—esophageal cancer	0.000227	0.00135	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP2A6—esophageal cancer	0.000225	0.00133	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFBR2—esophageal cancer	0.000225	0.00133	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000224	0.00133	CbGpPWpGaD
Clodronate—SLC25A4—Disease—XIAP—esophageal cancer	0.000223	0.00132	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALDOB—esophageal cancer	0.000219	0.0013	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP1B1—esophageal cancer	0.000216	0.00128	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS1—esophageal cancer	0.000213	0.00127	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ENO1—esophageal cancer	0.000213	0.00127	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SMAD4—esophageal cancer	0.000213	0.00126	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GAPDH—esophageal cancer	0.000211	0.00125	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PSME1—esophageal cancer	0.00021	0.00125	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PSME2—esophageal cancer	0.00021	0.00125	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CRABP1—esophageal cancer	0.000209	0.00124	CbGpPWpGaD
Clodronate—Pruritus—Methotrexate—esophageal cancer	0.000207	0.00217	CcSEcCtD
Clodronate—SLC25A4—Disease—B2M—esophageal cancer	0.000207	0.00123	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP19A1—esophageal cancer	0.000203	0.00121	CbGpPWpGaD
Clodronate—Diarrhoea—Methotrexate—esophageal cancer	0.000201	0.0021	CcSEcCtD
Clodronate—SLC25A4—Metabolism—GNG7—esophageal cancer	0.000199	0.00118	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ENO1—esophageal cancer	0.000199	0.00118	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PSME2—esophageal cancer	0.000196	0.00116	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PSME1—esophageal cancer	0.000196	0.00116	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFBR2—esophageal cancer	0.000188	0.00112	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CALR—esophageal cancer	0.000188	0.00112	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALDH2—esophageal cancer	0.000187	0.00111	CbGpPWpGaD
Clodronate—Vomiting—Methotrexate—esophageal cancer	0.000186	0.00195	CcSEcCtD
Clodronate—SLC25A5—Metabolism—HMOX1—esophageal cancer	0.000185	0.0011	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000185	0.0011	CbGpPWpGaD
Clodronate—Rash—Methotrexate—esophageal cancer	0.000185	0.00193	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—esophageal cancer	0.000185	0.00193	CcSEcCtD
Clodronate—SLC25A4—Disease—FBXW7—esophageal cancer	0.000182	0.00108	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP1B1—esophageal cancer	0.000181	0.00108	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SMAD4—esophageal cancer	0.000178	0.00106	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCB1—esophageal cancer	0.000178	0.00106	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTT1—esophageal cancer	0.000178	0.00105	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000176	0.00105	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP2A6—esophageal cancer	0.000175	0.00104	CbGpPWpGaD
Clodronate—Nausea—Methotrexate—esophageal cancer	0.000174	0.00182	CcSEcCtD
Clodronate—SLC25A5—Disease—HIF1A—esophageal cancer	0.000174	0.00103	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000173	0.00103	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP19A1—esophageal cancer	0.00017	0.00101	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS1—esophageal cancer	0.000166	0.000988	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ENO1—esophageal cancer	0.000166	0.000988	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PSME2—esophageal cancer	0.000164	0.000973	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PSME1—esophageal cancer	0.000164	0.000973	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CREBBP—esophageal cancer	0.00016	0.000948	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000159	0.000942	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—esophageal cancer	0.000158	0.00094	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000158	0.000937	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.000157	0.000931	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOTCH1—esophageal cancer	0.000157	0.000931	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HMOX1—esophageal cancer	0.000155	0.000923	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000153	0.000911	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000151	0.000896	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00015	0.000891	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCB1—esophageal cancer	0.000149	0.000886	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFBR2—esophageal cancer	0.000147	0.000872	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HIF1A—esophageal cancer	0.000146	0.000866	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	0.000142	0.000846	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CREBBP—esophageal cancer	0.000142	0.000844	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP1B1—esophageal cancer	0.000141	0.00084	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.00014	0.00083	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SMAD4—esophageal cancer	0.000139	0.000826	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	0.000138	0.000817	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	0.000135	0.000804	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP19A1—esophageal cancer	0.000133	0.00079	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—esophageal cancer	0.000133	0.000787	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOTCH1—esophageal cancer	0.000131	0.00078	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000128	0.000759	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS3—esophageal cancer	0.000127	0.000755	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000124	0.000735	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000124	0.000735	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HMOX1—esophageal cancer	0.000121	0.000721	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	0.000121	0.00072	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CREBBP—esophageal cancer	0.000119	0.000707	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CREBBP—esophageal cancer	0.000119	0.000707	CbGpPWpGaD
Clodronate—SLC25A5—Disease—ERBB2—esophageal cancer	0.000119	0.000707	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	0.000118	0.000701	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000117	0.000696	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCB1—esophageal cancer	0.000116	0.000692	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—esophageal cancer	0.000116	0.000691	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000114	0.000679	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HIF1A—esophageal cancer	0.000114	0.000676	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	0.000109	0.000646	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—esophageal cancer	0.000107	0.000633	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—esophageal cancer	0.000107	0.000633	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000107	0.000633	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—esophageal cancer	0.000104	0.000615	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOTCH1—esophageal cancer	0.000103	0.000609	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDKN1A—esophageal cancer	0.000102	0.000604	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CREBBP—esophageal cancer	9.97e-05	0.000592	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ERBB2—esophageal cancer	9.97e-05	0.000592	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC52A3—esophageal cancer	9.86e-05	0.000586	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—esophageal cancer	9.75e-05	0.000579	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—esophageal cancer	9.74e-05	0.000579	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EP300—esophageal cancer	9.68e-05	0.000575	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	9.48e-05	0.000563	CbGpPWpGaD
Clodronate—PTGS2—Disease—KMT2D—esophageal cancer	9.41e-05	0.000559	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.3e-05	0.000552	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CREBBP—esophageal cancer	9.29e-05	0.000552	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	9e-05	0.000534	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—esophageal cancer	8.93e-05	0.00053	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDKN1A—esophageal cancer	8.52e-05	0.000506	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MYC—esophageal cancer	8.43e-05	0.000501	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—esophageal cancer	8.32e-05	0.000494	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	8.31e-05	0.000494	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	8.28e-05	0.000491	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC52A3—esophageal cancer	8.26e-05	0.000491	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BLVRB—esophageal cancer	8.26e-05	0.000491	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EGFR—esophageal cancer	8.25e-05	0.00049	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—esophageal cancer	8.17e-05	0.000485	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EP300—esophageal cancer	8.11e-05	0.000482	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—EP300—esophageal cancer	8.1e-05	0.000481	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CREBBP—esophageal cancer	7.78e-05	0.000462	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ERBB2—esophageal cancer	7.78e-05	0.000462	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—esophageal cancer	7.61e-05	0.000452	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.38e-05	0.000438	CbGpPWpGaD
Clodronate—PTGS2—Disease—FKBP1A—esophageal cancer	7.3e-05	0.000433	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	7.22e-05	0.000429	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PIK3CA—esophageal cancer	7.16e-05	0.000425	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	7.13e-05	0.000424	CbGpPWpGaD
Clodronate—PTGS2—Disease—DOCK2—esophageal cancer	7.13e-05	0.000423	CbGpPWpGaD
Clodronate—PTGS2—Disease—WIF1—esophageal cancer	7.13e-05	0.000423	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—esophageal cancer	7.07e-05	0.00042	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	7.06e-05	0.000419	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA1—esophageal cancer	7.02e-05	0.000417	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC10A2—esophageal cancer	7.02e-05	0.000417	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—esophageal cancer	6.97e-05	0.000414	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.93e-05	0.000412	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—esophageal cancer	6.91e-05	0.00041	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—EP300—esophageal cancer	6.79e-05	0.000403	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1A—esophageal cancer	6.65e-05	0.000395	CbGpPWpGaD
Clodronate—PTGS2—Disease—CSNK1A1—esophageal cancer	6.58e-05	0.000391	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA2—esophageal cancer	6.42e-05	0.000381	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—esophageal cancer	6.37e-05	0.000379	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EP300—esophageal cancer	6.33e-05	0.000376	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.28e-05	0.000373	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.12e-05	0.000364	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CA—esophageal cancer	6e-05	0.000356	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CA—esophageal cancer	5.99e-05	0.000356	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLCE1—esophageal cancer	5.97e-05	0.000355	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADH7—esophageal cancer	5.97e-05	0.000355	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	5.93e-05	0.000352	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.92e-05	0.000352	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.9e-05	0.000351	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.64e-05	0.000335	CbGpPWpGaD
Clodronate—PTGS2—Disease—ELMO1—esophageal cancer	5.53e-05	0.000328	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—esophageal cancer	5.52e-05	0.000328	CbGpPWpGaD
Clodronate—PTGS2—Disease—GSTO1—esophageal cancer	5.4e-05	0.000321	CbGpPWpGaD
Clodronate—PTGS2—Disease—TPI1—esophageal cancer	5.4e-05	0.000321	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—esophageal cancer	5.4e-05	0.00032	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—EP300—esophageal cancer	5.3e-05	0.000315	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADH1B—esophageal cancer	5.24e-05	0.000311	CbGpPWpGaD
Clodronate—PTGS2—Disease—ALDOB—esophageal cancer	5.18e-05	0.000308	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CA—esophageal cancer	5.02e-05	0.000298	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TYMP—esophageal cancer	5e-05	0.000297	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIST1H2BM—esophageal cancer	4.99e-05	0.000296	CbGpPWpGaD
Clodronate—PTGS2—Disease—GAPDH—esophageal cancer	4.99e-05	0.000296	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.91e-05	0.000292	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP26A1—esophageal cancer	4.87e-05	0.000289	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.8e-05	0.000285	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALOX15—esophageal cancer	4.74e-05	0.000282	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CA—esophageal cancer	4.68e-05	0.000278	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TPI1—esophageal cancer	4.53e-05	0.000269	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTO1—esophageal cancer	4.53e-05	0.000269	CbGpPWpGaD
Clodronate—PTGS2—Disease—XIAP—esophageal cancer	4.41e-05	0.000262	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDOB—esophageal cancer	4.34e-05	0.000258	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GAPDH—esophageal cancer	4.18e-05	0.000248	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.17e-05	0.000248	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CRABP1—esophageal cancer	4.14e-05	0.000246	CbGpPWpGaD
Clodronate—PTGS2—Disease—B2M—esophageal cancer	4.1e-05	0.000243	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.03e-05	0.00024	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNG7—esophageal cancer	3.94e-05	0.000234	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO1—esophageal cancer	3.93e-05	0.000233	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CA—esophageal cancer	3.92e-05	0.000233	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSME1—esophageal cancer	3.87e-05	0.00023	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSME2—esophageal cancer	3.87e-05	0.00023	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALR—esophageal cancer	3.71e-05	0.00022	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDH2—esophageal cancer	3.69e-05	0.000219	CbGpPWpGaD
Clodronate—PTGS2—Disease—FBXW7—esophageal cancer	3.59e-05	0.000213	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTT1—esophageal cancer	3.51e-05	0.000208	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2A6—esophageal cancer	3.47e-05	0.000206	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.46e-05	0.000205	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTGS1—esophageal cancer	3.29e-05	0.000195	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO1—esophageal cancer	3.29e-05	0.000195	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PSME2—esophageal cancer	3.24e-05	0.000192	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PSME1—esophageal cancer	3.24e-05	0.000192	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFBR2—esophageal cancer	2.9e-05	0.000172	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1B1—esophageal cancer	2.8e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Disease—SMAD4—esophageal cancer	2.75e-05	0.000163	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP19A1—esophageal cancer	2.63e-05	0.000156	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—esophageal cancer	2.4e-05	0.000142	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.35e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—esophageal cancer	2.3e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIF1A—esophageal cancer	2.25e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—esophageal cancer	2.05e-05	0.000122	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOTCH1—esophageal cancer	2.03e-05	0.00012	CbGpPWpGaD
Clodronate—PTGS2—Disease—CREBBP—esophageal cancer	1.84e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.74e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—esophageal cancer	1.65e-05	9.77e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CREBBP—esophageal cancer	1.54e-05	9.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB2—esophageal cancer	1.54e-05	9.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—esophageal cancer	1.38e-05	8.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1A—esophageal cancer	1.32e-05	7.81e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EP300—esophageal cancer	1.25e-05	7.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—esophageal cancer	1.09e-05	6.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—esophageal cancer	1.07e-05	6.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—EP300—esophageal cancer	1.05e-05	6.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CA—esophageal cancer	9.26e-06	5.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CA—esophageal cancer	7.75e-06	4.6e-05	CbGpPWpGaD
